| Dabigatran iMpurity L |
达比加群杂质L |
1422435-41-3 |
| N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
硼替佐米杂质M |
289472-81-7 |
| Vildagliptin (2R)-Isomer |
(2R)-1-[2-[(3-羟基金刚烷-1-基)氨基]乙酰基]-2-吡咯烷甲腈 |
1036959-27-9 |
| Vildagliptin IMpurity 2 (Mixture of DiastereoMers) |
维达列汀杂质2(非对映体混合物) |
1036959-23-5 |
| Sitagliptin N-Boc IMpurity |
西他列汀N-BOC 杂质 |
486460-23-5 |
| 2-ALLYL-4-PENTENOIC ACID |
丙戊酸相关物质A |
99-67-2 |
| Tert-butyl((3s)-1-(7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-2,6-dioxo-2,3,4,5,6,7-hexahydro-1h-purin-8-yl)piperidin-3-yl)carbaMate |
叔丁氧羰基-利拉利汀 |
668273-75-4 |
| (3R,4R,5S)-ethyl 4-acetamido-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate |
奥司他韦中间体 |
651324-09-3 |
| 2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile |
2-氯-5-（2-氟苯基）-1H-吡咯-3-甲腈 |
1240948-72-4 |
| (3S,5R)-Rosuvastatin |
(3S,5R)-瑞舒伐他汀 |
1242184-42-4 |
| 3,5-bis(pyridin-4-yl)-4-amino-1,2,4-triazole |
3,5-双（吡啶-4-基）-4-氨基-1,2,4-三唑 |
38634-05-8 |
| (1S,2R,3R)-Aprepitant |
(1S,2R,3R)-阿瑞吡坦 |
1242175-34-3 |
| Bendamustine Impurity D |
苯达莫司汀杂质A |
191939-34-1 |
| Ascomycin |
长川霉素 |
104987-12-4 |
| 2-Hydroxy Atorvastatin Calcium Salt |
阿托伐他汀杂质2 |
265989-46-6 |
| FENOFIBRATE RELATED COMPOUND C (25 MG) (1-METHYLETHYL 2-[[2-[4-(4-CHLOROBENZOYL)PHENOXY]-2-METHYLPROPANOYL]OXY]-2-METHYLPROPANOATE) |
非诺贝特杂质G |
217636-48-1 |
| propan-2-yl 2-bromopropanoate |
2-溴丙酸异丙酯 |
7401-84-5 |
| Anecortave Acetate |
醋酸阿奈可他 |
7753-60-8 |
| NSC 23766 TETRAHYDROCHLORIDE |
N6-[2-[[4-(二乙基氨基)-1-甲基丁基]氨基]-6-甲基-4-嘧啶基]-2-甲基-4,6-喹啉二胺 |
733767-34-5 |
| N-cyano-N',N''-dimethylguanidine |
2-氰基-1,3-二甲基胍 |
31857-31-5 |
QQ
微信
